The present study is the first to show that the isogenic conversion of a PIK3CA-wild-type colon cancer cell into a PIK3CA-mutant cell line is sufficient to promote sensitization to aspirin. The gene discussed is PIK3CA; the disease is malignant colon neoplasm.